Management of nocturnal hypertension : An expert consensus document from Chinese Hypertension League
© 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC..
Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and all-cause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24-h ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24-h ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Long-acting antihypertensive medications are preferred for nocturnal and 24-h BP control. Some newly developed agents, renal denervation, and other device-based therapy on nocturnal BP reduction are evaluated.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Journal of clinical hypertension (Greenwich, Conn.) - 26(2024), 1 vom: 19. Jan., Seite 71-83 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Jing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antihypertensive Agents |
|---|
| Anmerkungen: |
Date Completed 19.01.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jch.14757 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366172891 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366172891 | ||
| 003 | DE-627 | ||
| 005 | 20240323000438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jch.14757 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM366172891 | ||
| 035 | |a (NLM)38126623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Jing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of nocturnal hypertension |b An expert consensus document from Chinese Hypertension League |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.01.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. | ||
| 520 | |a Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and all-cause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24-h ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24-h ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Long-acting antihypertensive medications are preferred for nocturnal and 24-h BP control. Some newly developed agents, renal denervation, and other device-based therapy on nocturnal BP reduction are evaluated | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a clinical management | |
| 650 | 4 | |a expert consensus | |
| 650 | 4 | |a nocturnal hypertension | |
| 650 | 7 | |a Sodium Chloride, Dietary |2 NLM | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Li, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Xinjun |e verfasserin |4 aut | |
| 700 | 1 | |a Bu, Peili |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Xueping |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Lizheng |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Yingqing |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Yifang |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Yinong |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yuming |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Jinxiu |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Long, Mingzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Mu, Jianjun |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Ningling |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Jianhong |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Jingyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Liangdi |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Zha, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Shanzhu |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jiguang |e verfasserin |4 aut | |
| 700 | 0 | |a Chinese Hypertension League expert consensus committee on the management of nocturnal hypertension |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical hypertension (Greenwich, Conn.) |d 1999 |g 26(2024), 1 vom: 19. Jan., Seite 71-83 |w (DE-627)NLM113204264 |x 1751-7176 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:1 |g day:19 |g month:01 |g pages:71-83 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jch.14757 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 1 |b 19 |c 01 |h 71-83 | ||